Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EWCO (Electrolyzed Water Company) is a specialized manufacturer of on-site electrolysis systems that produce hypochlorous acid (HOCl), a powerful and non-toxic antimicrobial solution. The company's technology, known as Electro-Chemical Activation (ECA), generates electrolyzed oxidizing water from salt, water, and electricity, providing a safe alternative to traditional chemical disinfectants like bleach. EWCO's systems are utilized across various industries, including healthcare, food and beverage, and agriculture, for applications such as surface disinfection, medical instrument sanitation, and wound care. The company's products are FDA-cleared and EPA-approved, offering a sustainable and effective solution for maintaining hygiene and controlling microbial pathogens. By enabling on-demand production of high-purity HOCl, EWCO helps organizations reduce their reliance on toxic chemicals while improving safety for both staff and patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EWCO.